Prevalence and Distribution of Goiter Among Commercially Insured, Working-Age Adults in the United States
Authors' conclusion
The prevalence of goiter, comprised predominantly of non-toxic multinodular goiter, is estimated to be 1.3-2.5% among working-age adults in the U.S. and varies by sex, age, and potentially by geography.
Study context
- Population
- Commercially insured adults aged 18–64 years in the US, Merative MarketScan Commercial Claims and Encounters Database 2022–2023
- Participants
- 15.2 million participants
- Outcome
- Goiter prevalence (ICD-10 diagnosis codes)
- Follow-up
- December 31, 2023
Methodological detailsclaims database analysis, nested case definitions
- Claims database analysis
- Nested case definitions
Main finding
As reported in the abstract
Overall goiter prevalence
Overall goiter prevalence (range across nested case definitions)
12.7-24.6 per 1000 persons
Observational data: associations, not effects.
Original publication
Prevalence and Distribution of Goiter Among Commercially Insured, Working-Age Adults in the United States. Thyroid. Published 20 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →